Bioprocess Technology Market Anticipated To Grow Steadily, Supported By Demand Drivers And Key Industry Trends.
What Is The Present Market Size Of The Bioprocess Technology Market, And At What Annual Growth Rate Is It Expanding?
The bioprocess technology market size has grown rapidly in recent years. It will grow from $28.71 billion in 2025 to $33.16 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing, increasing use of cell-based therapies, growth of research and development activities, rising demand for biologics, availability of advanced laboratory infrastructure.
The bioprocess technology market size is expected to see rapid growth in the next few years. It will grow to $59.03 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing investments in biologics and biosimilars, rising adoption of continuous bioprocessing, expansion of personalized medicine production, growing focus on sustainable biomanufacturing, increasing integration of digital process control systems. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising demand for scalable cell culture technologies, growing integration of automation in bioreactors, expansion of advanced cell line development techniques, enhanced focus on process optimization and yield efficiency.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9896&type=smp
Which Major Drivers Are Strengthening Demand In The Bioprocess Technology Market?
The increasing prevalence of chronic diseases is expected to propel the growth of the bioprocess technology market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Bioprocess technology in the development and production of gene therapies, vaccines, cell culture and fermentation and monoclonal antibody production for chronic diseases to advance in the field of medicine and improving the quality of life for individuals. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, that is 142.66 million, by 2050. Therefore, the increasing prevalence of chronic diseases drives the growth of the bioprocess technology market.
How Is The Bioprocess Technology Market Divided Across Its Major Segment Categories?
The bioprocess technology market covered in this report is segmented –
1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Filtration
2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid
3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users
Subsegments:
1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion
3) By Flow Cytometry: Cell Analysis, Cell Sorting
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Virus Filtration: Viral Vector Production, Virus Filtration Techniques
Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Bioprocess Technology Market?
Major companies operating in the bioprocess technology market are innovating services options, such as the custom organoid line expansion service, to gain a competitive edge in the market. The custom organoid line expansion service is a service that uses proprietary bioreactor and bioprocess technology to scale up the production of organoids. For instance, in July 2023, Molecular Devices LLC, a US-based Research and development company launched custom organoid line expansion service. The custom organoid line expansion service helps researchers to screen thousands to tens of thousands of drug candidates in parallel on organoids from the same source. It is designed to support next-generation drug discovery research and enables the development of more efficient, reproducible, and scalable patient-derived organoids (PDOs).
Which Influential Players Dominate The Competitive Environment Of The Bioprocess Technology Market?
Major companies operating in the bioprocess technology market are Sartorius AG; Thermo Fisher Scientific Inc.; Lonza Group AG; F. Hoffmann-La Roche Ltd.; Becton Dickinson and Company; Merck KGa; GE Healthcare; Eppendorf AG; Bio-Rad Laboratories; Catalent Inc.; Advanced Instruments LLC; MilliporeSigma; Repligen Corporation; Danaher Corporation; PerkinElmer Inc.; Applikon Biotechnology; New Brunswick Scientific Co. Inc.; Avid Bioservices; Meissner Filtration Products; 3M; Eppendorf Biochip Systems; Fermenter Bioreactor; Solaris Biotechnology Srl; Aber Instruments; Cytiva
Get Your In-Depth Bioprocess Technology Market Report Now:
https://www.thebusinessresearchcompany.com/report/bioprocess-technology-global-market-report
Which Geographic Markets Are Contributing Most Significantly To The Progress Of The Bioprocess Technology Market?
North America was the largest region in the bioprocess technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in the bioprocess technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment